Literature DB >> 17475935

Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.

Ki Chul Sung1, Marno C Ryan, Bum Soo Kim, Yong Kyun Cho, Byung Ik Kim, Gerald M Reaven.   

Abstract

OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD) is emerging as a major health problem in parallel with an increasing prevalence of obesity. Insulin resistance and abdominal and overall adiposity are closely associated with NAFLD; however, the interplay between them in the relationship with NAFLD is unclear, especially in nondiabetic individuals. RESEARCH DESIGN AND METHODS: Abdominal ultrasound, hepatitis serology, and measurements of fasting plasma insulin (FPI), lipid concentrations, overall obesity (BMI), and abdominal obesity (waist circumference) were performed in 56,249 Korean subjects.
RESULTS: After rigorous exclusion criteria, 36,654 nondiabetic subjects (54% male) were enrolled. Subjects were divided into control (no fatty liver on ultrasound, serum alanine aminotransferase [ALT] <30 units/l [men] or <19 units/l [women]), fatty liver with normal ALT (FL-NALT), and fatty liver with a high ALT (FL-HALT) groups. After adjusting for age, BMI, and waist circumference, FPI and ratio of triglycerides to HDL cholesterol (TG/HDL-C ratio) were significantly higher in the FL-NALT than in the control group and even higher in the FL-HALT group. Odds ratios for the presence of FL-HALT with increasing quartiles of FPI and TG/HDL-C ratio were increased five- to sevenfold over those of the control group, independent of age, BMI, and waist circumference.
CONCLUSIONS: In this large population of individuals of Korean ancestry, results indicate that while overall (BMI) and abdominal (waist circumference) overweight/obesity are associated with features of NAFLD, surrogate estimates of insulin resistance, FPI concentration, and TG/HDL-C ratio predict NAFLD independently of age, BMI, and waist circumference.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475935     DOI: 10.2337/dc07-0512

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  21 in total

Review 1.  Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.

Authors:  Qing Pang; Jing-Yao Zhang; Si-Dong Song; Kai Qu; Xin-Sen Xu; Su-Shun Liu; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

2.  Assessment of the relationship of hepatic enzymes with obesity and insulin resistance in adults in saudi arabia.

Authors:  Ali Ibrahim Al-Sultan
Journal:  Sultan Qaboos Univ Med J       Date:  2008-07

3.  Machine Learning Models in Type 2 Diabetes Risk Prediction: Results from a Cross-sectional Retrospective Study in Chinese Adults.

Authors:  Xiao-Lu Xiong; Rong-Xin Zhang; Yan Bi; Wei-Hong Zhou; Yun Yu; Da-Long Zhu
Journal:  Curr Med Sci       Date:  2019-07-25

4.  Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study.

Authors:  Jae Woong Lee; Yong Kyun Cho; Mc Ryan; Hyang Kim; Seung Won Lee; Eugene Chang; Kwan Joong Joo; Jung Tae Kim; Bum Soo Kim; Ki Chul Sung
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

5.  Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes.

Authors:  Ki-Chul Sung; Sun H Kim
Journal:  J Clin Endocrinol Metab       Date:  2011-01-20       Impact factor: 5.958

6.  Hepatocyte-specific deletion of BAP31 promotes SREBP1C activation, promotes hepatic lipid accumulation, and worsens IR in mice.

Authors:  Jia-Lin Xu; Li-Ya Li; Yan-Qing Wang; Ya-Qi Li; Mu Shan; Shi-Zhuo Sun; Yang Yu; Bing Wang
Journal:  J Lipid Res       Date:  2017-11-07       Impact factor: 5.922

7.  Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients.

Authors:  Adrian T Billeter; Jonas Senft; Daniel Gotthardt; Philipp Knefeli; Felix Nickel; Thilo Schulte; Lars Fischer; Peter P Nawroth; Markus W Büchler; Beat P Müller-Stich
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

8.  Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis.

Authors:  Milica Ćulafić; Sandra Vezmar-Kovačević; Violeta Dopsaj; Branislav Oluić; Nemanja Bidžić; Branislava Miljković; Đorđe Ćulafić
Journal:  J Med Biochem       Date:  2020-09-02       Impact factor: 3.402

9.  Usefulness of the high triglyceride-to-HDL cholesterol ratio to identify cardiometabolic risk factors and preclinical signs of organ damage in outpatient children.

Authors:  Procolo Di Bonito; Nicola Moio; Carolina Scilla; Luigi Cavuto; Gerolamo Sibilio; Eduardo Sanguigno; Claudia Forziato; Francesco Saitta; Maria Rosaria Iardino; Carla Di Carluccio; Brunella Capaldo
Journal:  Diabetes Care       Date:  2011-10-31       Impact factor: 19.112

10.  Adherence to the Mediterranean diet moderates the association of aminotransferases with the prevalence of the metabolic syndrome; the ATTICA study.

Authors:  Natalia Tzima; Christos Pitsavos; Demosthenes B Panagiotakos; Christina Chrysohoou; Evangelos Polychronopoulos; John Skoumas; Christodoulos Stefanadis
Journal:  Nutr Metab (Lond)       Date:  2009-07-30       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.